- Home
- Publications
- Publication Search
- Publication Details
Title
NY-ESO-1 (CTAG1B) expression in mesenchymal tumors
Authors
Keywords
-
Journal
MODERN PATHOLOGY
Volume 28, Issue 4, Pages 587-595
Publisher
Springer Nature
Online
2014-11-21
DOI
10.1038/modpathol.2014.155
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Localized and metastatic myxoid/round cell liposarcoma
- (2013) Aviad Hoffman et al. CANCER
- Mediator complex subunit 12 exon 2 mutation analysis in different subtypes of smooth muscle tumors confirms genetic heterogeneity
- (2013) Marieke A. de Graaff et al. HUMAN PATHOLOGY
- Activating transcription factor 2 in mesenchymal tumors
- (2013) Makoto Endo et al. HUMAN PATHOLOGY
- NY-ESO-1 is a sensitive and specific immunohistochemical marker for myxoid and round cell liposarcomas among related mesenchymal myxoid neoplasms
- (2013) Jessica A Hemminger et al. MODERN PATHOLOGY
- NY-ESO-1 is a ubiquitous immunotherapeutic target antigen for patients with myxoid/round cell liposarcoma
- (2012) Seth M. Pollack et al. CANCER
- NY-ESO-1 expression in synovial sarcoma and other mesenchymal tumors: significance for NY-ESO-1-based targeted therapy and differential diagnosis
- (2012) Jin-Ping Lai et al. MODERN PATHOLOGY
- The cancer-testis antigen NY-ESO-1 is highly expressed in myxoid and round cell subset of liposarcomas
- (2012) Jessica A Hemminger et al. MODERN PATHOLOGY
- Solitary fibrous tumor: a clinicopathological study of 110 cases and proposed risk assessment model
- (2012) Elizabeth G Demicco et al. MODERN PATHOLOGY
- NYESO-1/LAGE-1s and PRAME Are Targets for Antigen Specific T Cells in Chondrosarcoma following Treatment with 5-Aza-2-Deoxycitabine
- (2012) Seth M. Pollack et al. PLoS One
- Cartilage tumour progression is characterized by an increased expression of heparan sulphate 6O-sulphation-modifying enzymes
- (2012) Cathelijn J F Waaijer et al. VIRCHOWS ARCHIV
- Tumor Regression in Patients With Metastatic Synovial Cell Sarcoma and Melanoma Using Genetically Engineered Lymphocytes Reactive With NY-ESO-1
- (2011) Paul F. Robbins et al. JOURNAL OF CLINICAL ONCOLOGY
- Detection of myxoid liposarcoma-associated FUS–DDIT3 rearrangement variants including a newly identified breakpoint using an optimized RT-PCR assay
- (2010) Martin P Powers et al. MODERN PATHOLOGY
- Validation of immature adipogenic status and identification of prognostic biomarkers in myxoid liposarcoma using tissue microarrays
- (2009) Hongwei Cheng et al. HUMAN PATHOLOGY
- Osteosarcoma originates from mesenchymal stem cells in consequence of aneuploidization and genomic loss ofCdkn2
- (2009) Alexander B Mohseny et al. JOURNAL OF PATHOLOGY
- Myxoid tumours of soft tissue: the so-called myxoid extracellular matrix is heterogeneous in composition
- (2008) S M Willems et al. HISTOPATHOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation